Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(DL-lactide-co-glycolide)/dextran graft copolymer

Archives of Pharmacal Research

Volumn 31, Issue 11, 2008, Pages 1463-1469

  Bang, Je Yong ^a   Song, Chae Eun ^b   Kim, Chan ^c   Park, Woo Dae ^d   Cho, Ki Rae ^d   Kim, Pyoung Il ^e   Lee, Sang Rak ^f   Chung, Wan Tae ^g   Choi, Ki Choon ^d  

^a Seoul Women University   (South Korea)

^b Korea Institute of Natural Science Inc   (South Korea)

^c AMOMEDI Co Ltd   (South Korea)

^d Seojeong College University   (South Korea)

^e Seoul National University   (South Korea)

^f Konkuk University   (South Korea)

^g National Institute of Animal Science   (South Korea)

Author keywords

Amphotericin B; Candida albicans; Dextran; Poly(D,L lactide co glycolide); Polymeric micelle

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; DEXTRAN; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CANDIDA ALBICANS; CHEMISTRY; DRUG EFFECT; DRUG FORMULATION; ERYTHROCYTE; HEMOLYSIS; HUMAN; IN VITRO STUDY; MICELLE; MICROBIOLOGICAL EXAMINATION; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHEMISTRY, PHARMACEUTICAL; DEXTRANS; DRUG COMPOUNDING; ERYTHROCYTES; HEMOLYSIS; HUMANS; LACTIC ACID; MICELLES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; POLYGLYCOLIC ACID; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 56749175549     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-2131-0     Document Type: Article

References (20)

1. M. L. Adams G. S. Kwon 2003 Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly (ethylene oxide)-block-poly(N- hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length J. Control. Release 87 23 32
2. J. Barwicz S. Christian I. Gruda 1992 Effects of aggregation of amphotericin B on its toxicity to mice Antimicrob. Agents Chemother. 36 2310 2315
3. J. D. Berman 1997 Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in past 10 years Clin. Infect. Dis. 24 684 703
4. J. Bolard P. Legrand F. Heitz B. Cybulska 1991 One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium Biochemistry 30 5707 5715
5. K. C. Choi J. Y. Bang P. I. Kim C. Kim C. E. Song 2008 Amphotericin B-incorporated polymeric micelles composed of poly(d,l-lactide-co-glycolide)/ dextran graft copolymer Int. J. Pharm. 355 224 230
6. G. Deray 2002 Amphotericin B nephrotoxicity J. Antimicrob. Chemother. 49 37 41
7. B. Dupont 2002 Overview of the lipid formulations of amphotericin B J. Antimicrob. Chemother. 49 supplS1 31 36
8. H. A. Gallis R. H. Drew W. W. Pickard 1990 Amphotericin B: 30 years of clinical experience Rev. Infect. Dis. 12 308 329
9. R. Gref Y. Minamitake M. T. Peracchia V. Trubetskoy V. Torchilin R. Langer 1994 Biodegradable long-circulating polymeric nanospheres Science 263 1600 1603
10. A. H. Groll T. J. Walsh 2001 Uncommon opportunistic fungi: new nosocomial threats Clin. Microbiol. Infect.,z 7 Suppl2 8 24
11. K. Ichinose N. Tomiyama M. Nakashima Y. Ohya M. Ichikawa T. Ouchi T. Kanematsu 2000 Antitumor activity of dextran derivatives immobilizing platinum complex (II) Anticancer Drugs 11 33 38
12. K. Kataoka G. S. Kwon M. Yokohama T. Okano Y. Sakurai 1993 Block copolymer micelles as vehicles for drug delivery Journal of Controlled Release 24 119 132
13. M. Larabi V. Yardley P. M. Loiseau M. Appel P. Legrand A. Gulik C. Bories S. L. Croft G. Barrat 2003 Toxicity and Antileishmanial activity of a new stable lipid suspension of amphotericin B Antimicrob. Agents Chemother. 47 3774 3779
14. A. Lavasanifar J. Samuel S. Sattari G. S. Kwon 2002 Block copolymer micelles for the encapsulation and delivery of amphotericin B Pharm Res. 19 418 422
15. P. Legrand E. Romero J. P. Devissaguet B. Eleazar Cohen J. Bolard 1992 Effects of aggregation and solvent on toxicity of amphotericin B to human erythrocytes Antimicrob. Agents Chemother. 36 2518 2522
16. R. Mehvar 2003 Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives Current Pharmaceutical Biotechnology 4 283 302
17. T. J. Walsh J. Hiemenz E. Anaissie 1996 Recent progress and current problems in treatment of invasive fungal infections in neuropenic patients Infect. Dis. Clin. North Am. 10 365 400
18. G. Vandermeulen L. Rouxhet A. Arien M. E. Brewster V. Preat 2006 Encapsulation of amphotericin B in poly (ethylene glycol)-block-poly(- caprolactone-co-trimethylenecarbonate) polymeric micelles Int. J. Pharm. 309 234 240
19. V. Yardley S. J. Croft 1997 Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis Antimicrob. Agents Chemother. 41 752 756
20. B. Yu T. Okano K. Kataoka S. Sardari G. Kwon 1998 In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(β-benzyl-L-aspartate) micelles J. control. Release 56 285 291